Cures & Capital
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Cures & Capital
Jason O'Neill on cracking the code to successful drug launches - Part 2
In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.
This conversation is a practical guide to new drug launches, packed with Jason's hard-won insights. We explore why so many launches fail, the psychology behind adoption resistance, what meaningful relative advantage really means, how to plan for a successful launch, and when you actually need to start thinking about commercialization.
This episode will shift how you think about launching new drugs, and what it truly takes to do it successfully.
If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast
If you prefer to watch the episode as a video, you can also get the podcast from YouTube, just search for "Cures & Capital".
If you want to connect with Jason:
Linkedin: https://www.linkedin.com/in/jason-o-neill-1b8a2349/
You can get his new book "The secrets of successful drug launches" from:
Amazon: https://www.amazon.com/Secrets-Successful-Drug-Launches/dp/B0DZ6RFTCN
This book is packed with insights and practical tips, and all proceeds go to the Prostate Cancer Foundation in memory of Jason’s father. Buying it is truly a win-win, you gain valuable knowledge while supporting a meaningful cause.
Links to some of the articles and books that we discussed in this episode:
McKinsey's analysis on "Pharma’s first-to-market advantage"
Link: https://www.mckinsey.com/industries/life-sciences/our-insights/pharmas-first-to-market-advantage#/
Paper: "Pharmaceutical forecasting: throwing darts?"
Link: https://www.nature.com/articles/nrd4127
HBR articles:
"Eager Sellers and Stony Buyers: Understanding the Psychology of New-Product Adoption"
Link: https://hbr.org/2006/06/eager-sellers-and-stony-buyers-understanding-the-psychology-of-new-product-adoption
"Marketing Malpractice: The Cause and the Cure"
Link: https://hbr.org/2005/12/marketing-malpractice-the-cause-and-the-cure
"What is Strategy?"
Link: https://hbr.org/1996/11/what-is-strategy
"The Hidden Traps in Decision Making"
Link: https://hbr.org/1998/09/the-hidden-traps-in-decision-making-2
Books:
"Diffusion of Innovation"
Link: https://www.goodreads.com/book/show/75599989-diffusion-of-innovations-5th-edition?from_search=true&from_srp=true&qid=HrX5m6p9k8&rank=2
"Poor Charlie's Almanack: The Wit and Wisdom of Charles T. Munger"
Link: https://www.goodreads.com/book/show/944652.Poor_Charlie_s_Almanack
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
